Botulax 100 Units Injection (Botulinum Toxin Type A)

Botulax 100 Units Injection is a prescription-only injectable formulation containing Botulinum Toxin Type A, a purified neurotoxic protein produced through controlled fermentation and purification processes. This product is widely recognized within regulated medical and pharmaceutical environments and is supplied strictly for institutional and professional use. AmeriDrugs provides Botulax 100 Units Injection exclusively for export-oriented pharmaceutical supply chains.

Active Ingredient

• Botulinum Toxin Type A – 100 Units per vial
  Botulinum Toxin Type A acts at the neuromuscular junction by inhibiting neurotransmitter release under controlled clinical conditions, as defined by approved medical and regulatory frameworks.

Therapeutic Use
From an informational and regulatory standpoint, Botulax 100 Units Injection is supplied to licensed healthcare providers and institutions for use in approved therapeutic and procedural applications, subject to country-specific regulatory approvals. This content is intended solely for product identification and trade information. AmeriDrugs does not provide medical advice, treatment protocols, or patient-facing recommendations.

Dosage Form

• Sterile lyophilized powder for injection

• Supplied in single-use pharmaceutical-grade glass vials

• Reconstitution, administration route, and clinical use are determined exclusively by qualified medical professionals in compliance with local regulations

Quality & Manufacturing Standards
Botulax 100 Units Injection is manufactured in GMP-compliant facilities operating under stringent quality management systems. Production involves validated aseptic processes, biological activity testing, and stability controls to ensure batch-to-batch consistency, safety, and compliance with international pharmaceutical export standards.

Packaging Information

• Glass vial sealed with rubber stopper and aluminium cap

• Secure secondary carton packaging designed for export logistics

• Cold-chain handling and storage requirements may apply depending on regulatory and manufacturer specifications

Target Buyers
This product is intended exclusively for supply to:

• Licensed pharmaceutical importers and distributors

• Hospitals and specialized medical centres

• Clinics operating under authorized medical supervision

• Government tenders and regulated healthcare procurement agencies

It is not intended for retail sale or direct-to-consumer distribution.

Regulatory & Compliance Note
Botulax 100 Units Injection contains Botulinum Toxin Type A, a controlled prescription-only biological product. It is supplied strictly for professional medical use within licensed healthcare settings. Importation, storage, distribution, and utilization must comply with the pharmaceutical laws and regulatory requirements of the destination country. AmeriDrugs operates solely as an export-focused pharmaceutical supplier and does not promote this product for self-use, cosmetic retail sale, or non-regulated applications.